Peginterferon beta-1a

(Plegridy®)

Plegridy®

Drug updated on 11/13/2023

Dosage FormInjection (subcutaneous: 125mg/0.5mL, 63mg/0.5mL, 94mg/0.5mL)
Drug ClassInterferon beta
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.